Vaccines for the prevention of diseases caused by potential bioweapons

Morad Hassani, Mahesh C. Patel, Liise-anne Pirofski

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The development of vaccines and implementation of vaccination programs are among the most important medical contributions to humanity. To date, vaccination has reduced morbidity and mortality from infectious diseases more than any other specific medical intervention. The intentional use of bioweapons against civilians (bioterrorism), recently highlighted by events around the world, has fueled interest in the development of vaccines for potential microbial agents of bioterror. This review discusses the microbial agents that are considered to pose the greatest risk to the public, the diseases associated with them, and the vaccines that are available for their prevention. The paucity of such vaccines and uncertainty regarding mechanisms of vaccine efficacy and the microbial antigens that elicit protection underscore the need for continued study of host-microbe interaction and the immune response to potential agents of bioterror for the development of new vaccines and immune-based therapies to combat their potential to harm the public.

Original languageEnglish (US)
Pages (from-to)1-15
Number of pages15
JournalClinical Immunology
Volume111
Issue number1
DOIs
StatePublished - Apr 2004

Fingerprint

Vaccines
Vaccination
Bioterrorism
Uncertainty
Communicable Diseases
Morbidity
Antigens
Mortality
Therapeutics

Keywords

  • Anthrax
  • Bioterror
  • Category A agents
  • Plague
  • Q fever
  • Smallpox
  • Toxin
  • Tularemia
  • Vaccine
  • Viral hemorrhagic fever

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Vaccines for the prevention of diseases caused by potential bioweapons. / Hassani, Morad; Patel, Mahesh C.; Pirofski, Liise-anne.

In: Clinical Immunology, Vol. 111, No. 1, 04.2004, p. 1-15.

Research output: Contribution to journalArticle

Hassani, Morad ; Patel, Mahesh C. ; Pirofski, Liise-anne. / Vaccines for the prevention of diseases caused by potential bioweapons. In: Clinical Immunology. 2004 ; Vol. 111, No. 1. pp. 1-15.
@article{fe12a754318f419da1e66b6ff9726bc5,
title = "Vaccines for the prevention of diseases caused by potential bioweapons",
abstract = "The development of vaccines and implementation of vaccination programs are among the most important medical contributions to humanity. To date, vaccination has reduced morbidity and mortality from infectious diseases more than any other specific medical intervention. The intentional use of bioweapons against civilians (bioterrorism), recently highlighted by events around the world, has fueled interest in the development of vaccines for potential microbial agents of bioterror. This review discusses the microbial agents that are considered to pose the greatest risk to the public, the diseases associated with them, and the vaccines that are available for their prevention. The paucity of such vaccines and uncertainty regarding mechanisms of vaccine efficacy and the microbial antigens that elicit protection underscore the need for continued study of host-microbe interaction and the immune response to potential agents of bioterror for the development of new vaccines and immune-based therapies to combat their potential to harm the public.",
keywords = "Anthrax, Bioterror, Category A agents, Plague, Q fever, Smallpox, Toxin, Tularemia, Vaccine, Viral hemorrhagic fever",
author = "Morad Hassani and Patel, {Mahesh C.} and Liise-anne Pirofski",
year = "2004",
month = "4",
doi = "10.1016/j.clim.2003.09.010",
language = "English (US)",
volume = "111",
pages = "1--15",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Vaccines for the prevention of diseases caused by potential bioweapons

AU - Hassani, Morad

AU - Patel, Mahesh C.

AU - Pirofski, Liise-anne

PY - 2004/4

Y1 - 2004/4

N2 - The development of vaccines and implementation of vaccination programs are among the most important medical contributions to humanity. To date, vaccination has reduced morbidity and mortality from infectious diseases more than any other specific medical intervention. The intentional use of bioweapons against civilians (bioterrorism), recently highlighted by events around the world, has fueled interest in the development of vaccines for potential microbial agents of bioterror. This review discusses the microbial agents that are considered to pose the greatest risk to the public, the diseases associated with them, and the vaccines that are available for their prevention. The paucity of such vaccines and uncertainty regarding mechanisms of vaccine efficacy and the microbial antigens that elicit protection underscore the need for continued study of host-microbe interaction and the immune response to potential agents of bioterror for the development of new vaccines and immune-based therapies to combat their potential to harm the public.

AB - The development of vaccines and implementation of vaccination programs are among the most important medical contributions to humanity. To date, vaccination has reduced morbidity and mortality from infectious diseases more than any other specific medical intervention. The intentional use of bioweapons against civilians (bioterrorism), recently highlighted by events around the world, has fueled interest in the development of vaccines for potential microbial agents of bioterror. This review discusses the microbial agents that are considered to pose the greatest risk to the public, the diseases associated with them, and the vaccines that are available for their prevention. The paucity of such vaccines and uncertainty regarding mechanisms of vaccine efficacy and the microbial antigens that elicit protection underscore the need for continued study of host-microbe interaction and the immune response to potential agents of bioterror for the development of new vaccines and immune-based therapies to combat their potential to harm the public.

KW - Anthrax

KW - Bioterror

KW - Category A agents

KW - Plague

KW - Q fever

KW - Smallpox

KW - Toxin

KW - Tularemia

KW - Vaccine

KW - Viral hemorrhagic fever

UR - http://www.scopus.com/inward/record.url?scp=1842735260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842735260&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2003.09.010

DO - 10.1016/j.clim.2003.09.010

M3 - Article

C2 - 15093546

AN - SCOPUS:1842735260

VL - 111

SP - 1

EP - 15

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 1

ER -